期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Investigation of degradation and recovery characteristics of NBTI in 28-nm high-k metal gate process
1
作者 巩伟泰 李闫 +2 位作者 孙亚宾 石艳玲 李小进 《Chinese Physics B》 SCIE EI CAS CSCD 2023年第12期628-635,共8页
Degradation induced by the negative bias temperature instability(NBTI)can be attributed to three mutually uncoupled physical mechanisms,i.e.,the generation of interface traps(ΔV_(IT)),hole trapping in pre-existing ga... Degradation induced by the negative bias temperature instability(NBTI)can be attributed to three mutually uncoupled physical mechanisms,i.e.,the generation of interface traps(ΔV_(IT)),hole trapping in pre-existing gate oxide defects(ΔV_(HT)),and the generation of gate oxide defects(ΔV_(OT)).In this work,the characteristic of NBTI for p-type MOSFET fabricated by using a 28-nm high-k metal gate(HKMG)process is thoroughly studied.The experimental results show that the degradation is enhanced at a larger stress bias and higher temperature.The effects of the three underlying subcomponents are evaluated by using the comprehensive models.It is found that the generation of interface traps dominates the NBTI degradation during long-time NBTI stress.Moreover,the NBTI parameters of the power-law time exponent and temperature activation energy as well as the gate oxide field acceleration are extracted.The dependence of operating lifetime on stress bias and temperature is also discussed.It is observed that NBTI lifetime significantly decreases as the stress increases.Furthermore,the decrease of charges related to interface traps and hole detrapping in pre-existing gate oxide defects are used to explain the recovery mechanism after stress. 展开更多
关键词 negative bias temperature instability(NBTI) high-k metal gate(HKMG) threshold voltage shift interface trap gate oxide defect
原文传递
Effect of neoadjuvant chemotherapy on the expression of hormone receptors and Ki67 in Chinese breast cancer patients:A retrospective study of 525 patients 被引量:6
2
作者 Yu-tuan Wu Xin Li +6 位作者 Lin-jie Lu Lu Gan Wei Dai yan-ling shi Vishnu Prasad Adhikari Kai-nan Wu Ling-quan Kong 《The Journal of Biomedical Research》 CAS CSCD 2018年第3期191-197,共7页
This study was designed to investigate the effect of neoadjuvant chemotherapy on the expression of hormone receptors and Ki67 in Chinese female breast cancer patients. The expression of estrogen receptor(ER), proges... This study was designed to investigate the effect of neoadjuvant chemotherapy on the expression of hormone receptors and Ki67 in Chinese female breast cancer patients. The expression of estrogen receptor(ER), progesterone receptor(PR) and Ki67 among 525 neoadjuvant chemotherapy cases was studied by immunohistochemistry.Differences between specimens made through preoperative core needle biopsy and excised tissue biopsy were observed. The positive rates of ER, PR and Ki67 in core needle biopsy and excised tissue biopsy were 65.3% and 63.2%, 51.0% and 42.6%, 65.6% and 43.4%, respectively. The expression of ER, PR and Ki67 in core needle biopsy and excised tissue biopsy had no statistically significant difference. However, after neoadjuvant chemotherapy, the discordance rates of ER, PR and Ki67 were 15.2%(79/521), 26.9%(140/520) and 44.8%(225/502), respectively. The ER, PR and Ki67 status changed from positive to negative in 7.5%(39/521), 13.3%(69/520) and 21.1%(106/502) of the patients, whereas ER, PR and Ki67 status changed from negative to positive in 7.7%(40/521), 13.6%(71/520)and 23.7%(119/502) of the patients, respectively. These results showed that the status of some biomarkers changes after neoadjuvant chemotherapy and biomarker status needs to be reexamined to optimize adjuvant systemic therapy and better prognosis assessment. 展开更多
关键词 breast cancer neoadjuvant chemotherapy hormone receptors Ki67
下载PDF
Thyrotoxicosis Occurring in Secondary Hyperparathyroidism Patients Undergoing Dialysis after Total Parathyroidectomy with Autotransplantation 被引量:5
3
作者 Zhou Xu Yu-Tuan Wu +7 位作者 Xin Li He Wu Hao-Ran Chen yan-ling shi Bilal Arshad Hong-Yuan Li Kai-Nan Wu Ling-Quart Kong 《Chinese Medical Journal》 SCIE CAS CSCD 2017年第16期1995-1996,共2页
Secondary hyperparathyroidism (SHPT) is a common complication in chronic kidney disease (CKD) that is characterized by excessive synthesis of parathyroid hormone (PTH) and parathyroid hyperplasia.The prevalence ... Secondary hyperparathyroidism (SHPT) is a common complication in chronic kidney disease (CKD) that is characterized by excessive synthesis of parathyroid hormone (PTH) and parathyroid hyperplasia.The prevalence of CKD is estimated to be 5-10%, and the burden of CKD-associated diseases is alarmingly high.Despite advances in medical therapy for SHPT, surgical parathyroidectomy remains the definitive therapy for refractory SHPT, which drastically decreases PTH levels and ameliorates symptoms related to severe SHPT. 展开更多
关键词 Autotransplantation: Dialysis PARATHYROIDECTOMY Secondary Hyperparathyroidism THYROTOXICOSIS
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部